TrialFrontiers in pediatrics2026

The efficacy and safety of combined 0.01% atropine and orthokeratology for childhood myopia control: a 2-year randomized clinical trial.

Ying Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.